{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T21:36:38Z","timestamp":1792100198423,"version":"4.4.0"},"reference-count":74,"publisher":"American Society of Hematology","issue":"7","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2019,8,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Painful vaso-occlusive crisis (VOC) is the most common complication of sickle cell disease (SCD). Increasing evidence suggests that vaso-occlusion is initiated by increased adherence of sickle red blood cells (RBCs) to the vascular endothelium. Thus, the mechanisms that remove endothelial-attached sickle RBCs from the microvasculature are expected to be critical for optimal blood flow and prevention of VOC in SCD. We hypothesized that patrolling monocytes (PMos), which protect against vascular damage by scavenging cellular debris, could remove endothelial-adherent sickle RBCs and ameliorate VOC in SCD. We detected RBC (GPA+)-engulfed material in circulating PMos of patients with SCD, and their frequency was further increased during acute crisis. RBC uptake by PMos was specific to endothelial-attached sickle, but not control, RBCs and occurred mostly through ICAM-1, CD11a, and CD18. Heme oxygenase 1 induction, by counteracting the cytotoxic effects of engulfed RBC breakdown products, increased PMo viability. In addition, transfusions, by lowering sickle RBC uptake, improved PMo survival. Selective depletion of PMos in Townes sickle mice exacerbated vascular stasis and tissue damage, whereas treatment with muramyl dipeptide (NOD2 ligand), which increases PMo mass, reduced stasis and SCD associated organ damage. Altogether, these data demonstrate a novel mechanism for removal of endothelial attached sickle RBCs mediated by PMos that can protect against VOC pathogenesis, further supporting PMos as a promising therapeutic target in SCD VOC.<\/jats:p>","DOI":"10.1182\/blood.2019000172","type":"journal-article","created":{"date-parts":[[2019,5,10]],"date-time":"2019-05-10T19:05:14Z","timestamp":1557515114000},"page":"579-590","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":33,"title":["Patrolling monocytes scavenge endothelial-adherent sickle RBCs: a novel mechanism of inhibition of vaso-occlusion in SCD"],"prefix":"10.1182","volume":"134","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9187-4146","authenticated-orcid":false,"given":"Yunfeng","family":"Liu","sequence":"first","affiliation":[{"name":"Lindsley F. Kimball Research Institute, New York Blood Center, New York, NY;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Zhong","sequence":"additional","affiliation":[{"name":"Lindsley F. Kimball Research Institute, New York Blood Center, New York, NY;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weili","family":"Bao","sequence":"additional","affiliation":[{"name":"Lindsley F. Kimball Research Institute, New York Blood Center, New York, NY;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Avital","family":"Mendelson","sequence":"additional","affiliation":[{"name":"Lindsley F. Kimball Research Institute, New York Blood Center, New York, NY;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuli","family":"An","sequence":"additional","affiliation":[{"name":"Lindsley F. Kimball Research Institute, New York Blood Center, New York, NY;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Shi","sequence":"additional","affiliation":[{"name":"Lindsley F. Kimball Research Institute, New York Blood Center, New York, NY;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stella T.","family":"Chou","sequence":"additional","affiliation":[{"name":"Division of Hematology, Children\u2019s Hospital of Philadelphia, Philadelphia, PA; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepa","family":"Manwani","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Albert Einstein College of Medicine, Bronx, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karina","family":"Yazdanbakhsh","sequence":"additional","affiliation":[{"name":"Lindsley F. Kimball Research Institute, New York Blood Center, New York, NY;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"24","key":"2020021109251480600_B1","doi-asserted-by":"crossref","first-page":"3892","DOI":"10.1182\/blood-2013-05-498311","article-title":"Vaso-occlusion in sickle cell disease: pathophysiology and novel targeted therapies","volume":"122","author":"Manwani","year":"2013","journal-title":"Blood"},{"issue":"1","key":"2020021109251480600_B2","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1146\/annurev-genom-083117-021320","article-title":"Sickle cell anemia and its phenotypes","volume":"19","author":"Williams","year":"2018","journal-title":"Annu Rev Genomics Hum Genet"},{"issue":"2","key":"2020021109251480600_B3","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/s41573-018-0003-2","article-title":"Therapeutic strategies for sickle cell disease: towards a multi-agent approach","volume":"18","author":"Telen","year":"2019","journal-title":"Nat Rev Drug Discov"},{"issue":"6","key":"2020021109251480600_B4","doi-asserted-by":"crossref","first-page":"2845","DOI":"10.1172\/JCI118355","article-title":"In vivo demonstration of red cell-endothelial interaction, sickling and altered microvascular response to oxygen in the sickle transgenic mouse","volume":"96","author":"Kaul","year":"1995","journal-title":"J Clin Invest"},{"issue":"1","key":"2020021109251480600_B5","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1146\/annurev-pathmechdis-012418-012838","article-title":"Pathophysiology of sickle cell disease","volume":"14","author":"Sundd","year":"2019","journal-title":"Annu Rev Pathol"},{"key":"2020021109251480600_B6","doi-asserted-by":"crossref","first-page":"18010","DOI":"10.1038\/nrdp.2018.10","article-title":"Sickle cell disease","volume":"4","author":"Kato","year":"2018","journal-title":"Nat Rev Dis Primers"},{"issue":"18","key":"2020021109251480600_B7","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1056\/NEJM198005013021803","article-title":"Erythrocyte adherence to endothelium in sickle-cell anemia. A possible determinant of disease severity","volume":"302","author":"Hebbel","year":"1980","journal-title":"N Engl J Med"},{"issue":"4","key":"2020021109251480600_B8","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1172\/JCI112144","article-title":"Sickle erythrocyte adherence to vascular endothelium. Morphologic correlates and the requirement for divalent cations and collagen-binding plasma proteins","volume":"76","author":"Mohandas","year":"1985","journal-title":"J Clin Invest"},{"issue":"10","key":"2020021109251480600_B9","doi-asserted-by":"crossref","first-page":"3232","DOI":"10.1182\/blood.V95.10.3232","article-title":"Perfusion with sickle erythrocytes up-regulates ICAM-1 and VCAM-1 gene expression in cultured human endothelial cells","volume":"95","author":"Shiu","year":"2000","journal-title":"Blood"},{"issue":"11","key":"2020021109251480600_B10","doi-asserted-by":"crossref","first-page":"4845","DOI":"10.1182\/blood.V87.11.4845.bloodjournal87114845","article-title":"Adhesion of sickle red blood cells and damage to interleukin-1 beta stimulated endothelial cells under flow in vitro","volume":"87","author":"Natarajan","year":"1996","journal-title":"Blood"},{"issue":"10","key":"2020021109251480600_B11","doi-asserted-by":"crossref","first-page":"3924","DOI":"10.1182\/blood.V92.10.3924","article-title":"Interaction of sickle erythrocytes with endothelial cells in the presence of endothelial cell conditioned medium induces oxidant stress leading to transendothelial migration of monocytes","volume":"92","author":"Sultana","year":"1998","journal-title":"Blood"},{"issue":"7","key":"2020021109251480600_B12","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1182\/blood-2015-09-618538","article-title":"Neutrophils, platelets, and inflammatory pathways at the nexus of sickle cell disease pathophysiology","volume":"127","author":"Zhang","year":"2016","journal-title":"Blood"},{"issue":"2","key":"2020021109251480600_B13","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1161\/ATVBAHA.109.196360","article-title":"Human sickle cell blood modulates endothelial heme oxygenase activity: effects on vascular adhesion and reactivity","volume":"30","author":"Bains","year":"2010","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"2","key":"2020021109251480600_B14","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/S0165-6147(00)01609-6","article-title":"Heme-induced cell adhesion in the pathogenesis of sickle-cell disease and inflammation","volume":"22","author":"Wagener","year":"2001","journal-title":"Trends Pharmacol Sci"},{"key":"2020021109251480600_B15","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/831596","article-title":"Vasculotoxic and proinflammatory effects of plasma heme: cell signaling and cytoprotective responses","volume":"2013","author":"Belcher","year":"2013","journal-title":"ISRN Oxidative Med"},{"issue":"3","key":"2020021109251480600_B16","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1172\/JCI89741","article-title":"Intravascular hemolysis and the pathophysiology of sickle cell disease","volume":"127","author":"Kato","year":"2017","journal-title":"J Clin Invest"},{"key":"2020021109251480600_B17","doi-asserted-by":"crossref","first-page":"415","DOI":"10.3389\/fphys.2014.00415","article-title":"Haptoglobin, hemopexin, and related defense pathways-basic science, clinical perspectives, and drug development","volume":"5","author":"Schaer","year":"2014","journal-title":"Front Physiol"},{"issue":"5","key":"2020021109251480600_B18","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1182\/blood.V32.5.811.811","article-title":"Plasma concentrations of hemopexin, haptoglobin and heme in patients with various hemolytic diseases","volume":"32","author":"Muller-Eberhard","year":"1968","journal-title":"Blood"},{"issue":"2","key":"2020021109251480600_B19","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1089\/ars.2009.2787","article-title":"Heme scavenging and the other facets of hemopexin","volume":"12","author":"Tolosano","year":"2010","journal-title":"Antioxid Redox Signal"},{"issue":"1","key":"2020021109251480600_B20","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1146\/annurev.pharmtox.010909.105600","article-title":"Mechanisms of cell protection by heme oxygenase-1","volume":"50","author":"Gozzelino","year":"2010","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"4","key":"2020021109251480600_B21","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.coph.2009.05.008","article-title":"Immunoregulatory effects of HO-1: how does it work?","volume":"9","author":"Soares","year":"2009","journal-title":"Curr Opin Pharmacol"},{"issue":"14","key":"2020021109251480600_B22","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1182\/blood-2017-12-819870","article-title":"HO-1hi patrolling monocytes protect against vaso-occlusion in sickle cell disease","volume":"131","author":"Liu","year":"2018","journal-title":"Blood"},{"issue":"1","key":"2020021109251480600_B23","doi-asserted-by":"crossref","first-page":"102","DOI":"10.4049\/jimmunol.1400105","article-title":"Hemin controls T cell polarization in sickle cell alloimmunization","volume":"193","author":"Zhong","year":"2014","journal-title":"J Immunol"},{"issue":"14","key":"2020021109251480600_B24","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1182\/blood-2018-02-832139","article-title":"Patrolling the endothelium in sickle cell disease","volume":"131","author":"Gordeuk","year":"2018","journal-title":"Blood"},{"issue":"7","key":"2020021109251480600_B25","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1182\/blood.V76.7.1431.1431","article-title":"Transfusion and alloimmunization in sickle cell disease","volume":"76","author":"Rosse","year":"1990","journal-title":"Blood"},{"issue":"3","key":"2020021109251480600_B26","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1182\/blood-2011-11-327361","article-title":"Red blood cell alloimmunization in sickle cell disease: pathophysiology, risk factors, and transfusion management","volume":"120","author":"Yazdanbakhsh","year":"2012","journal-title":"Blood"},{"issue":"3","key":"2020021109251480600_B27","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.hoc.2016.01.011","article-title":"Management of patients with sickle cell disease using transfusion therapy: guidelines and complications","volume":"30","author":"Chou","year":"2016","journal-title":"Hematol Oncol Clin North Am"},{"issue":"2","key":"2020021109251480600_B28","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/bjh.14346","article-title":"Guidelines on red cell transfusion in sickle cell disease. Part I: principles and laboratory aspects","volume":"176","author":"Davis","year":"2017","journal-title":"Br J Haematol"},{"issue":"2","key":"2020021109251480600_B29","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/pbc.24179","article-title":"Indications and complications of transfusions in sickle cell disease","volume":"59","author":"Smith-Whitley","year":"2012","journal-title":"Pediatr Blood Cancer"},{"issue":"10","key":"2020021109251480600_B30","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1001\/jama.2014.10517","article-title":"Management of sickle cell disease: summary of the 2014 evidence-based report by expert panel members","volume":"312","author":"Yawn","year":"2014","journal-title":"JAMA"},{"issue":"3","key":"2020021109251480600_B31","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.celrep.2013.10.010","article-title":"Real-time in vivo imaging reveals the ability of monocytes to clear vascular amyloid beta","volume":"5","author":"Michaud","year":"2013","journal-title":"Cell Reports"},{"issue":"2","key":"2020021109251480600_B32","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.cell.2013.03.010","article-title":"Nr4a1-dependent Ly6C(low) monocytes monitor endothelial cells and orchestrate their disposal","volume":"153","author":"Carlin","year":"2013","journal-title":"Cell"},{"issue":"6263","key":"2020021109251480600_B33","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1126\/science.aac9407","article-title":"Patrolling monocytes control tumor metastasis to the lung","volume":"350","author":"Hanna","year":"2015","journal-title":"Science"},{"issue":"8","key":"2020021109251480600_B34","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1016\/j.celrep.2017.08.009","article-title":"Triggering of NOD2 receptor converts inflammatory Ly6Chigh into Ly6Clow monocytes with patrolling properties","volume":"20","author":"Lessard","year":"2017","journal-title":"Cell Reports"},{"issue":"6","key":"2020021109251480600_B35","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/j.immuni.2011.11.009","article-title":"Monocyte subsets responsible for immunoglobulin G-dependent effector functions in vivo","volume":"35","author":"Biburger","year":"2011","journal-title":"Immunity"},{"issue":"12","key":"2020021109251480600_B36","doi-asserted-by":"crossref","first-page":"2789","DOI":"10.1002\/eji.201646406","article-title":"NR4A1-dependent Ly6Clow monocytes contribute to reducing joint inflammation in arthritic mice through Treg cells","volume":"46","author":"Brunet","year":"2016","journal-title":"Eur J Immunol"},{"issue":"5838","key":"2020021109251480600_B37","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1126\/science.1142883","article-title":"Monitoring of blood vessels and tissues by a population of monocytes with patrolling behavior","volume":"317","author":"Auffray","year":"2007","journal-title":"Science"},{"issue":"1-2","key":"2020021109251480600_B38","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.tracli.2008.03.011","article-title":"Adhesion of sickle red cells to endothelium: myths and future directions","volume":"15","author":"Hebbel","year":"2008","journal-title":"Transfus Clin Biol"},{"issue":"4","key":"2020021109251480600_B39","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1159\/000204892","article-title":"Monocyte phagocytic activity in sickle cell disease","volume":"85","author":"Mendoza","year":"1991","journal-title":"Acta Haematol"},{"issue":"4","key":"2020021109251480600_B40","doi-asserted-by":"crossref","first-page":"e0196455","DOI":"10.1371\/journal.pone.0196455","article-title":"Haptoglobin and hemopexin inhibit vaso-occlusion and inflammation in murine sickle cell disease: role of heme oxygenase-1 induction","volume":"13","author":"Belcher","year":"2018","journal-title":"PLoS One"},{"issue":"4","key":"2020021109251480600_B41","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1182\/blood.V54.4.872.872","article-title":"Adhesion of normal and sickle erythrocytes to endothelial monolayer cultures","volume":"54","author":"Hoover","year":"1979","journal-title":"Blood"},{"issue":"1","key":"2020021109251480600_B42","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1172\/JCI109646","article-title":"Abnormal adherence of sickle erythrocytes to cultured vascular endothelium: possible mechanism for microvascular occlusion in sickle cell disease","volume":"65","author":"Hebbel","year":"1980","journal-title":"J Clin Invest"},{"issue":"1","key":"2020021109251480600_B43","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1182\/blood.V64.1.282.282","article-title":"Adherence of sickle erythrocytes to vascular endothelial cells: requirement for both cell membrane changes and plasma factors","volume":"64","author":"Mohandas","year":"1984","journal-title":"Blood"},{"issue":"24","key":"2020021109251480600_B44","doi-asserted-by":"crossref","first-page":"2654","DOI":"10.1182\/blood-2017-04-780635","article-title":"Extracellular fluid tonicity impacts sickle red blood cell deformability and adhesion","volume":"130","author":"Carden","year":"2017","journal-title":"Blood"},{"issue":"2","key":"2020021109251480600_B45","first-page":"102","article-title":"Erythrocyte adhesion in sickle cell disease","volume":"2","author":"Parise","year":"2003","journal-title":"Curr Hematol Rep"},{"issue":"5","key":"2020021109251480600_B46","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1182\/blood.V99.5.1564","article-title":"Role of erythrocyte phosphatidylserine in sickle red cell-endothelial adhesion","volume":"99","author":"Setty","year":"2002","journal-title":"Blood"},{"issue":"10","key":"2020021109251480600_B47","doi-asserted-by":"crossref","first-page":"3006","DOI":"10.1182\/blood.V83.10.3006.3006","article-title":"Adhesion of sickle cells to vascular endothelium is critically dependent on changes in density and shape of the cells","volume":"83","author":"Kaul","year":"1994","journal-title":"Blood"},{"issue":"2","key":"2020021109251480600_B48","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1182\/blood.V68.2.450.450","article-title":"Association between morphologic distortion of sickle cells and deoxygenation-induced cation permeability increase","volume":"68","author":"Mohandas","year":"1986","journal-title":"Blood"},{"issue":"2","key":"2020021109251480600_B49","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1089\/ars.2009.2822","article-title":"Heme degradation and vascular injury","volume":"12","author":"Belcher","year":"2010","journal-title":"Antioxid Redox Signal"},{"key":"2020021109251480600_B50","article-title":"Red blood cell adhesion to heme-activated endothelial cells reflects clinical phenotype in sickle cell disease [published online ahead of print 15 June 2018]","author":"Kucukal","journal-title":"Am J Hematol"},{"issue":"12","key":"2020021109251480600_B51","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1161\/CIRCULATIONAHA.112.130179","article-title":"Hemopexin therapy improves cardiovascular function by preventing heme-induced endothelial toxicity in mouse models of hemolytic diseases","volume":"127","author":"Vinchi","year":"2013","journal-title":"Circulation"},{"issue":"6","key":"2020021109251480600_B52","doi-asserted-by":"crossref","first-page":"3553","DOI":"10.4049\/jimmunol.172.6.3553","article-title":"Heme oxygenase-1 modulates the expression of adhesion molecules associated with endothelial cell activation","volume":"172","author":"Soares","year":"2004","journal-title":"J Immunol"},{"issue":"24","key":"2020021109251480600_B53","doi-asserted-by":"crossref","first-page":"3805","DOI":"10.1182\/blood-2014-07-589283","article-title":"Circulating cell membrane microparticles transfer heme to endothelial cells and trigger vasoocclusions in sickle cell disease","volume":"125","author":"Camus","year":"2015","journal-title":"Blood"},{"issue":"1","key":"2020021109251480600_B54","doi-asserted-by":"crossref","first-page":"e89761","DOI":"10.1172\/jci.insight.89761","article-title":"Lung vaso-occlusion in sickle cell disease mediated by arteriolar neutrophil-platelet microemboli","volume":"2","author":"Bennewitz","year":"2017","journal-title":"JCI Insight"},{"issue":"3","key":"2020021109251480600_B55","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1111\/bjh.14137","article-title":"Low molecular weight heparin inhibits sickle erythrocyte adhesion to VCAM-1 through VLA-4 blockade in a standardized microfluidic flow adhesion assay","volume":"178","author":"Lancelot","year":"2017","journal-title":"Br J Haematol"},{"issue":"2","key":"2020021109251480600_B56","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1182\/blood-2010-05-285718","article-title":"Inhibition of cell adhesion by anti-P-selectin aptamer: a new potential therapeutic agent for sickle cell disease","volume":"117","author":"Gutsaeva","year":"2011","journal-title":"Blood"},{"issue":"5","key":"2020021109251480600_B57","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1056\/NEJMoa1611770","article-title":"Crizanlizumab for the prevention of pain crises in sickle cell disease","volume":"376","author":"Ataga","year":"2017","journal-title":"N Engl J Med"},{"issue":"17","key":"2020021109251480600_B58","doi-asserted-by":"crossref","first-page":"2656","DOI":"10.1182\/blood-2014-06-583351","article-title":"Randomized phase 2 study of GMI-1070 in SCD: reduction in time to resolution of vaso-occlusive events and decreased opioid use","volume":"125","author":"Telen","year":"2015","journal-title":"Blood"},{"issue":"1","key":"2020021109251480600_B59","first-page":"29","article-title":"Human monocytes CD36 and CD16 are signaling molecules. Evidence from studies using antibody-induced chemiluminescence as a tool to probe signal transduction","volume":"71","author":"Trezzini","year":"1990","journal-title":"Immunology"},{"issue":"1","key":"2020021109251480600_B60","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1189\/jlb.0510249","article-title":"Robust erythrophagocytosis leads to macrophage apoptosis via a hemin-mediated redox imbalance: role in hemolytic disorders","volume":"89","author":"Cambos","year":"2011","journal-title":"J Leukoc Biol"},{"issue":"6","key":"2020021109251480600_B61","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1038\/nri2779","article-title":"Phagocyte partnership during the onset and resolution of inflammation","volume":"10","author":"Soehnlein","year":"2010","journal-title":"Nat Rev Immunol"},{"key":"2020021109251480600_B62","doi-asserted-by":"crossref","first-page":"387","DOI":"10.3389\/fphys.2013.00387","article-title":"Mechanisms tagging senescent red blood cells for clearance in healthy humans","volume":"4","author":"Lutz","year":"2013","journal-title":"Front Physiol"},{"issue":"4","key":"2020021109251480600_B63","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1002\/ajh.20196","article-title":"Cytokine profile of sickle cell disease in Oman","volume":"77","author":"Pathare","year":"2004","journal-title":"Am J Hematol"},{"issue":"7","key":"2020021109251480600_B64","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1002\/ajh.23736","article-title":"Reduction in serum IL-10 levels is a surrogate marker for predicting vaso-occlusive crisis in sickle cell disease","volume":"89","author":"Sarray","year":"2014","journal-title":"Am J Hematol"},{"issue":"1","key":"2020021109251480600_B65","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.cyto.2014.11.030","article-title":"Serum IL-6, IL-10, and TNF\u03b1 levels in pediatric sickle cell disease patients during vasoocclusive crisis and steady state condition","volume":"72","author":"Sarray","year":"2015","journal-title":"Cytokine"},{"issue":"1","key":"2020021109251480600_B66","doi-asserted-by":"crossref","first-page":"13886","DOI":"10.1038\/srep13886","article-title":"Non-classical monocytes display inflammatory features: validation in sepsis and systemic lupus erythematous","volume":"5","author":"Mukherjee","year":"2015","journal-title":"Sci Rep"},{"issue":"1-3","key":"2020021109251480600_B67","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s12026-012-8297-3","article-title":"The three human monocyte subsets: implications for health and disease","volume":"53","author":"Wong","year":"2012","journal-title":"Immunol Res"},{"issue":"23","key":"2020021109251480600_B68","doi-asserted-by":"crossref","first-page":"2581","DOI":"10.1182\/blood-2017-12-822619","article-title":"Increased erythrophagocytosis induces ferroptosis in red pulp macrophages in a mouse model of transfusion","volume":"131","author":"Youssef","year":"2018","journal-title":"Blood"},{"issue":"3","key":"2020021109251480600_B69","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1172\/JCI26857","article-title":"Heme oxygenase-1 is a modulator of inflammation and vaso-occlusion in transgenic sickle mice","volume":"116","author":"Belcher","year":"2006","journal-title":"J Clin Invest"},{"issue":"1","key":"2020021109251480600_B70","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1089\/ars.2010.3153","article-title":"Heme oxygenase in the regulation of vascular biology: from molecular mechanisms to therapeutic opportunities","volume":"14","author":"Kim","year":"2011","journal-title":"Antioxid Redox Signal"},{"issue":"1","key":"2020021109251480600_B71","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/s41598-017-00220-w","article-title":"Specific expression of heme oxygenase-1 by myeloid cells modulates renal ischemia-reperfusion injury","volume":"7","author":"Rossi","year":"2017","journal-title":"Sci Rep"},{"issue":"10","key":"2020021109251480600_B72","doi-asserted-by":"crossref","first-page":"6730","DOI":"10.4049\/jimmunol.181.10.6730","article-title":"Lipopolysaccharide-induced expression of NAD(P)H:quinone oxidoreductase 1 and heme oxygenase-1 protects against excessive inflammatory responses in human monocytes","volume":"181","author":"Rushworth","year":"2008","journal-title":"J Immunol"},{"issue":"1","key":"2020021109251480600_B73","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/nri3565","article-title":"NOD proteins: regulators of inflammation in health and disease [published correction appears in Nat Rev Immunol. 2014;14(2):131]","volume":"14","author":"Philpott","year":"2014","journal-title":"Nat Rev Immunol"},{"issue":"219","key":"2020021109251480600_B74","doi-asserted-by":"crossref","first-page":"219ra7","DOI":"10.1126\/scitranslmed.3007563","article-title":"Therapeutic inflammatory monocyte modulation using immune-modifying microparticles","volume":"6","author":"Getts","year":"2014","journal-title":"Sci Transl Med"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/134\/7\/579\/1554396\/bloodbld2019000172.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/134\/7\/579\/1554396\/bloodbld2019000172.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,11]],"date-time":"2020-02-11T10:08:36Z","timestamp":1581415716000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/134\/7\/579\/260733\/Patrolling-monocytes-scavenge-endothelialadherent"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,15]]},"references-count":74,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2019,8,15]]}},"URL":"https:\/\/doi.org\/10.1182\/blood.2019000172","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,15]]}}}